Recruiting cancer survivors with trouble sleeping to understand experiences and preferences for insomnia treatment
Summary
Have you been diagnosed with cancer? Do you also have trouble falling asleep or staying asleep? Or are you a healthcare provider who works with cancer survivors? We want to hear about your experiences with treatment for cancer-related sleep difficulties.
Many cancer survivors will have trouble falling asleep and staying asleep after their cancer diagnosis. However, it can be hard for people with cancer to find non-medicine options to help them sleep better because there are not enough trained healthcare providers available. Peer support is widely available across Canada, and we believe that lay peers can be trained to treat sleep problems. With this study, we will ask cancer survivors, peer supporters, and healthcare providers about the treatments currently offered to cancer survivors for sleep problems and their opinions on a new treatment delivered by peers using online surveys and interviews. The information we collect will help us develop a new peer support program to help treat sleep problems among cancer survivors.
Eligibility
Eligible ages: 18 to 100
Inclusion criteria:
Cancer survivors: Individuals diagnosed with 1) any type or stage of cancer who are 2) 18 years of age or older, 3) able to read, write, and speak English and 4) having sleep problems or disturbances like trouble falling asleep, staying asleep, or waking up too early.
Peer support workers: Individuals who are 1) diagnosed with any type or stage of cancer, 2) facilitate a peer support group or program, 3) 18 years of age or older, and 4) can read, write, and speak English.
Healthcare providers: Individuals who are 1) licensed to provide healthcare services and 2) work directly with cancer survivors.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Anyone interested in participating can self-refer to the study. For more information or to determine your eligibility please call Joshua Tulk at 403-210-8606 or email joshua.tulk@ucalgary.ca.
Principal investigator:
Tavis Campbell
Clinical trial:
No
REB-ID:
HREBA.CC-24-0384